Neuropeptide YY5 receptor protein in the cortical/limbic system and brainstem of the rat:: Expression on γ-aminobutyric acid and corticotropin-releasing hormone neurons

被引:45
作者
Grove, KL [1 ]
Campbell, RE
Ffrench-Mullen, JMH
Cowley, MA
Smith, MS
机构
[1] Oregon Hlth & Sci Univ, Div Neurosci, Beaverton, OR 97006 USA
[2] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Beaverton, OR 97006 USA
[3] Oregon Hlth & Sci Univ, Vollum Inst, Beaverton, OR 97006 USA
关键词
cortex; hippocampus; immunocytochemistry; interneurons; dentate gyrus;
D O I
10.1016/S0306-4522(00)00308-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neuropeptide Y displays diverse modes of action in the CNS including the modulation of cortical/limbic function. Some of these physiological actions have been at least partially attributed to actions of neuropeptide Y on the Y5 receptor subtype. We utilized an antibody raised against the Y5 receptor to characterize the distribution of this receptor subtype in the rat cortical/ limbic system and brainstem. Y5-like immunoreactivity was located primarily in neuronal cell bodies and proximal dendritic processes throughout the brain. In the cortex, Y5 immunoreactivity was limited to a subpopulation of small gamma -aminobutyric-acid interneurons (approximately 15 mum diameter) scattered throughout all cortical levels. Double label immunofluorescence was also used to demonstrate that all of the Y5 immunoreactive neurons in the cortex displayed intense corticotropin releasing hormone immunoreactivity. The most intense Y5 immunoreactive staining in the hippocampus was located in the pyramidal cell layer of the small CA2 subregion and the fasciola cinerea, with lower levels of staining in the hilar region of the dentate gyrus and CA3 subregion of the pyramidal cell layer. Nearly all of the Y5 immunoreactive neurons in the hilar region of the hippocampus displayed gamma -aminobutyric-acid immunoreactivity. In the brainstem, Y5 immunoreactivity was most intense in the Edinger-Westphal nucleus, locus coeruleus and the mesencephalic trigeminal nucleus. The present study provides neuroanatomical evidence for the possible sites of action of the neuropeptide Y/Y5 receptor system in the control of cortical/limbic function. The presence of Y5 immunoreactivity on cell bodies and proximal dendritic processes in specific regions of the hippocampus suggests that this receptor functions to modulate postsynaptic activity. These data also suggest that the neuropeptide Y/Y5 system may play a role in the modulation of a specific population of GABAergic neurons in the cortex, namely those that contain corticotropin-releasing hormone. The location of the Y5 receptor immunoreactivity fits with the known physiological actions of neuropeptide Y and this receptor. (C) 2000 IBRO. Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:731 / 740
页数:10
相关论文
共 68 条
[1]   CORTICOTROPIN RELEASING-FACTOR DECREASES POSTBURST HYPERPOLARIZATIONS AND EXCITES HIPPOCAMPAL-NEURONS [J].
ALDENHOFF, JB ;
GRUOL, DL ;
RIVIER, J ;
VALE, W ;
SIGGINS, GR .
SCIENCE, 1983, 221 (4613) :875-877
[2]  
AOKI C, 1990, ANN NY ACAD SCI, V611, P186
[3]   EXPRESSION OF NEUROPEPTIDES IN THE RAT MESENCEPHALIC TRIGEMINAL NUCLEUS AFTER PERIPHERAL AXOTOMY [J].
ARVIDSSON, J ;
RAAPPANA, P ;
DIEZ, M ;
HOKFELT, T .
NEUROREPORT, 1994, 5 (10) :1269-1272
[4]   Neuropeptide Y family of hormones: Receptor subtypes and antagonists [J].
Balasubramaniam, A .
PEPTIDES, 1997, 18 (03) :445-457
[5]   Neuropeptide Y suppresses epileptiform activity in rat frontal cortex and hippocampus in vitro via different NPY receptor subtypes [J].
Bijak, M .
NEUROSCIENCE LETTERS, 1999, 268 (03) :115-118
[6]  
Bittencourt JC, 1999, J COMP NEUROL, V415, P285
[7]   Y-receptor subtypes - How many more? [J].
Blomqvist, AG ;
Herzog, H .
TRENDS IN NEUROSCIENCES, 1997, 20 (07) :294-298
[8]   Anxiolytic activity of NPY receptor agonists in the conflict test [J].
Britton, KT ;
Southerland, S ;
VanUden, E ;
Kirby, D ;
Rivier, J ;
Koob, G .
PSYCHOPHARMACOLOGY, 1997, 132 (01) :6-13
[9]  
BROWN TH, 1990, SYNAPTIC ORG BRAIN
[10]  
CAMPBELL RE, 2000, ENDOCRINE SOC J, V82, P267